Feasibility and Toxicity of Concomitant Radio/Immunotherapy with MabThera (Rituximab®) for Patients with Non-Hodkin's Lymphoma
暂无分享,去创建一个
M. Steurer | P. Lukas | A. Haidenberger | E. Gunsilius | I. Skvortsova | Bela-Andre Popper | A. Vries | Sabine Fromm-Haidenberger | J. Kantner